Democracy Dies in Darkness

Omicron variant more resistant to vaccine but causes less severe covid, major South African study concludes

By
Updated December 14, 2021 at 6:13 p.m. EST|Published December 14, 2021 at 4:14 a.m. EST
South Africa health insurer Discovery Health reported on Dec. 14 that the omicron variant is more resistant to vaccines but has less severe symptoms. (Video: AP)
correction

An earlier version of this article said the study in South Africa was based on 211,000 coronavirus cases, of which 78,000 were attributed to omicron, according to an initial news release distributed by Discovery Health. The story has been corrected to reflect subsequently released information from the company indicating that the positive cases the study attributed to omicron were far fewer than it initially reported.

CAPE TOWN, South Africa — Omicron appears to cause less severe illness than earlier variants of the coronavirus but is more resistant to the two-dose Pfizer-BioNTech vaccine widely used in South Africa, according to a major private study of the variant.

The study by Discovery Health, South Africa’s largest health insurer, showed that risk of hospital admissions among adults who developed covid-19 was 29 percent lower than in the initial pandemic wave that emerged in March 2020.